Hayek Kallen Investment Management lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 2,342.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 148,527 shares of the healthcare product maker's stock after p